BIBLIOGRAFÍA

1. Lombardo L. Mateos JH. Cerebral cysticercosis in México. Nemolog 1961; 11; 824-28
   
   

2. Ministerio de Salud Pública & Rotary Club Quite Valle Interoceánico ed. Teniasis y cisticercosis en el Ecuador. Quite. Imprenta del Ministerio de Salud Pública, 1991. 

3. Díaz F. García HH. Et. al. Epidemiology of taeniasis and cysticercosis in a Peruvian village Am j, Epidemiol 1992; 135 875-882 
   
   

4. Botere, D. Estudio sobre cisticercosis en Colombia Rev, UIS Medicina Bucaramanga(Colombia) 1986, 14, 19-34. 
   
   

5. Coker-Vann MR, Subianto DB. Brown P, et al ELISA antiantibodies to cysticerci of Taenia solium in human population in New Guinea, Oceania and Southeast Asia Southeast Asian J Trop Med Public Health 1981,12; 499-505
   
   

6. Briceño C, Biagi F. Martinez B, Cisticercosis. Observaciones de 97 casos de autopsia Prensa Med Mex 1961,26 193-97
   
   

7. Costa-Cruz LM, Rocha A, Silva AM, et al Ocorrencia de cisticercose em necropcias realizadas en Uberlandia, Minas Gerais, Brasil Arq Neuropsiquiat 1995; 53 227-32
   
   

8. García HIA, Martinez M, GiIman R, et al Diagnosis of cysticercosis in endemic regions. Lancet 1991, 338: 549-51
   
   

9. Del Brutto OH, Santibañez R, Noboa CA, Aguarre R, Díaz E. Alarcón TA. Epilepsy due to neurocysticercosis analysis of 203 patients. Neurology 1992, 42; 389 - 92
   
   

10. López-Hernandez A, Garaizar C. Childhood cerebral cysticercosis clinical features and computed tomographic in 99 Mexican children. Can J Neural Sci 1982; 9: 401-07
    
    

11. Cabieses F. Vallenas M, Landa R, Cisticercosis of the dorsal spinal cord J Neurosurg 1959; 16: 337-41
    
    

12. Venkatarama NK, Jain VK, Das BS, Rao TV Intramedullary cysticercosis. Clin Neurol Neurosurg 1989, 91, 337-41.
    
    

13. Akiguchi I, Fujiwara T. Matsuyama R Muranaka H, Kameyama M. Intramedullary spinal cysticercosis Neurology 1979; 29: 1953-34
    
    

14. Firemark HM Spinal cysticercosis, Arch Neurol 1978; 35-250-51
    
    

15. Grogl M, Estrada JJ. McDonald G. Kuhn RE Antigen-antigen - antibody analyses in nourocysticercosis. J parasitol 1985; 71: 433-42
    
    

16. Del Brutto OH, Sotelo J. Etiopatogenia de la neurocisticercosis, Rev Ecuat Neurol 1993; 2: 22-32
    
    

17. Flisser A. Woodhouse E. Larralde C. Human cysticercosis; antigens, antibodies and non-responders, Clin Exp Immunol 1980; 39: 27-37
    
    

18. Estañol B, Kleriga E, Loyo M, et al. Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy Neurosurgery 1983,13 119-23,
    
    

19. Siqueira EB, Richardson RR, Kranzier LI. Cysticercosis cerebri occluding the foramen of Monro. Surg Neurol 1980; 13: 429-31
    
    

20. De Bruto OH, Garcia E, Talamas O, Sotelo J. Sex-related severity of inflammation in parenchymal brain cysticercosis Arch intern Med 1988; 148: 544 - 46
    
    

21. García HH Gilman R, Martinez M, et Al. Cysticercosis as a major cause of epilepsy in Peru. Lancet 1993; 341, 197-200
    
    

22. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J, Neurocysticercosis as the main cause of late-onset epilepsy in Mexico Arch Inter Med 1990, 150,323-25
    
    

23. Del Brutto OH. CT findings in neurologicaly normal adults with a single generalized seizure. J Epilepsy 1994; 7: 38-40
    
    

24. Arellano Sánchez J, Aruffo C, Escobar, A Cisticercosis del IV ventrículo and sindrome de Bruns Rev Fac Med UNAM (Mex) 1985; 28: 11-19
    
    

25. Cárdenas F, Quiroz H, Plancarte A, Meza Dalma A flisser A Taenia solium ocular cysticercosis findings in 30 cases. Ann Ophthalmol 1992; 24: 25-28
    
    

26. MacCormick GF, Giannotta S, ZeeC-S, Fisher M. Carotid occlusion in cysticercosis. Neurology 1983; 33: 1078-80
    
    

27. Rodriguez-Carbajal J, Del Brutto OH, Penagos P, Huebe J. Escobar A Occlusion of the middle cerebral artery due to cysticercotic angiitis Stroke 1989; 20: 1095-99
    
    

28. Ter-Pennig B, Litchman C, Heir L., Bilateral middle cerebral artery occlusions in neurocysticercosis, Stroke 1992-; 23: 280-83
    
    

29. Levy AS Lillehei KO, Robinstein D, Stears JC Subarachnoid neurocysticercosis with occlusion of major intracranial arteries; case report. Neurosurgery 1995; 36: 183-88
    
    

30. Tsang VCW, Brand J, Boyer E. Enzyme-linked immunoelectrotransferency blot assay and glycoprotein Antigens for diagnosing human cysticercosis. J. Infect Dis 1989, 159; 50-59
    
    

31. Rosas N, Sotelo, Nieto D, Elisa in the diagnosis of neurocysticercosis. Arch Neurol 1986; 43: 353-56
    
    

32. Garcia E, Sotelo J, Anew complement fixation test for the diagnosis of neurocysticercosis in cerebroespinal fluid. J Neurol 1991; 238: 379-92
    
    

33. Robles C, Chavarria M. Presentación de un caso clínico de cisticercosis cerebral tratado médicamente con un nuevo fármaco: praziquantel, Salud Pub Mex. 1979; 21: 603-61 8,
    
    

34. Sotelo J, Escobedo F, Rodriguez-Carbajal J, Torres; B, Rubio-Donuadieu F, Therapy of parenchymal brain, cysticercosis with, praziquantel N EngI J Med 1994; 301: 1001-107
    
    

35. Robles C. Sedano AM, Vargas-Tentori N, Galindo – Virgen S. Long – Term results of praziquantel therapy in neurocysticercosis J Neurosurg 1987; 66: 359-363
    
    

36. Escobedo F, Penagos P, Rodriguez J, Sotelo J. Albendazole therapy for neurocysticercosis. Arch Intern Med 1987; 147; 738-741
    
    

37. Sotelo J, Penagos P, Escobedo F, Del Brutto OH Short course of albendazole therapy for neurocysticercosis. Arch Neural 1988; 45: 1130-1133
    
    

38. Sotelo J, Del Brutto OH, Penagos P, at al. Comparison of therapeutic regimen anticysticercal drugs for parenchymal brain cysticercosis, J Neurol 1990; 237: 69-71
    
    

39. Takayanagui OM, Jarmin E. Therapy for neurocysticercosis: comparison between albendazole and praziquantel. Arch Neurol 1992; 49: 290:294
    
    

40. Vásquez N, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992,327 696-701
    
    

41. Santoyo H, Corona R, Sotelo J. Total recovery of visual function after treatment for cerebral cysticercosis N Engl J Med 1991; 324: 1137-1139
    
    

42. Del Brutto OH, Sotelo J, Aguirre R, Díaz-calderón E, Alarcon TA. Albendazole therapy for giant subarachnoid cysticerci. Arch Neurol 1992; 49: 535-538
    
    

43. Medina MT, Genton P, Montoya MC, Córdova S, Dravet C, Sotelo J. Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial, Epilepsy 1993; 34: 1024-27
    
    

44. Bittencourt PRM, Gracia CM, Martins R, Fernandes AG, Diekmann HW, Jung W. Phenytoin and carbamazepine decrease oral biovailability of praziquantel. Neurology 1992; 42: 492-496
    
    

45. Del Brutto OH. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 1994; 44: 1706-1709
    
    

46. Vázquez ML, Jung H, Sotelo J. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously Neurology 1987; 37: 1561-1562
    
    

47. Jung H, Hurtado M, Medina MT, Sanchéz M, Sotelo J. Dexamethasone increases plasma levels of albendazole J Neurol 1990; 237: 279-280
    
    

48. Neal JH, An endoscopic approach to cysticercosis cysts of the posterior third ventricle. Neuro surgery 1995; 36: 1040-43
    
    

49. Kramer J, Carranza E, Cosgrove G, et al. Transaqueductal migration of a neurocysticercus cyst. J. Neurosurg 1992; 77: 956-58.
    

50. Colli BO, Pereira CU, Assirati JA Jr. Machado Isolated fourth ventricle in neurocysticercosis: pathophysiology diagnosis, and treatment Surg Neurol 1993; 305-10
    
    

51. Del Brutto O, Sotelo J. Albendazole therapy for subarachnoid and ventricular cysticercosis. J Neurosurg, 1990; 72: 816-17.
    
    

52. Allcut D, Coulthard A. Neurocysticercosis: regression of a fourth ventricular cyst with praziquantel. J Neurol Neurosurg Psychiat 1991; 54: 461-62.